Associations were also seen when the cases were stratified based on presentation. Overall, our findings do not support the hypothesis that common TOR1A variants affect susceptibility for sporadic primary dystonia, and that it is unlikely that common variants around the DYT genes confer substantial risk for sporadic primary dystonia. Further work is warranted to follow up the GCH1 SNPs and the subgroup analyses.
Introduction
Primary dystonia is a group of related movement disorders characterised by abnormal repetitive, twisting postures due to the involuntary co-contraction of opposing muscle groups. This is thought to arise from a dysfunction of the central neural circuits that control and coordinate voluntary movements, such as those found in the basal ganglia [1] , the cerebellum [2] , the sensorimotor cortex [3] , and the interactions between these three regions of the brain [4] . While the rare early-onset forms of dystonia can sometimes be traced to inherited genetic abnormalities, the more common late-onset forms arise sporadically with no clear aetiology [1] .
It has been postulated that the sporadic forms of primary dystonia are caused by an interaction between genetic and non-genetic factors [5] . Sporadic primary dystonia is comprised of multiple phenotypic subtypes, classified by bodily presentation and distribution. However, the prevalence of primary dystonia is relatively low in the general population with the average European prevalence estimated at 152 cases per million and the estimated prevalence of each subtype substantially lower [6] . While there may be subtype-specific risk factors [7] [8] [9] , there may also be susceptibility factors that are common to all sporadic primary dystonias. Given that the different subtypes can co-present in individual patients (concurrently at onset or sequentially) and that many seem to share neurophysiological similarities [5] , it seems valid to group these subtypes into a single phenotype to identify such shared risk factors. The purpose of this study is to identify shared genetic risk factors for the sporadic primary dystonias.
To date there have been at least 17 genetic loci linked to familial forms of dystonia. At eight of these loci, causative mutations have been found in so-called DYT genes. These mutations cause rare and usually early-onset forms of familial dystonia or "dystonia plus" syndromes, including torsion dystonia (for example, DYT1, DYT6), myoclonus dystonia (DYT11), dystonia-parkinsonism (DYT3, DYT12, DYT16), paroxysmal/episodic dyskensia (DYT8) and dopa-responsive dystonia (DYT5) (for background information regarding these Newman et al. 4 dystonia syndromes, please refer to Supplementary References). While these disorders display a rather disparate phenotypic spectrum dystonia is often prominent in these disorders, if not the only presenting symptom [10, 11] . It is therefore an attractive option to investigate these genes as candidates for sporadic primary dystonia. This approach to candidate susceptibility loci has been employed with some success for other neurological diseases which have known genetic causes in a small proportion of cases; good examples include Parkinson's disease [12] and Alzheimer's disease [13] .
To date there have been few published candidate genes association studies examining sporadic primary dystonia, and only two of the known DYT genes, TOR1A (DYT1) and THAP1 (DYT6), have been studied. Six candidate genes studies have examined common single nucleotide polymorphisms (SNPs) in and around the TOR1A gene. Two of these studies showed strong associations between individual SNPs and susceptibility for primary dystonia in populations from Iceland [14] , southern Germany and Austria [15] , and the United States [16] .
Others have shown modest associations in Indian, Italian and northern German populations [7, 8, 17] . However, other similar studies have not replicated these findings [8, 18, 19] . In contrast to TOR1A, no strong associations have been reported with polymorphisms in the THAP1 gene [20, 21] , although rare variants within the THAP1 coding regions may be a cause of some adultonset cases [22] .
Here we looked to extend the previous studies by testing the hypothesis that common SNPs in various DYT genes influence the susceptibility to sporadic primary dystonia in a wellcharacterised Australian case-control sample. First, we used a similar haplotype-tagging approach to that of Kamm et al. [15] to cover the common genetic variability in TOR1A followed by a meta-analysis of four previously studied TOR1A SNPs. We then applied haplotype-tagging approaches to investigate seven other DYT genes:
(DYT12) and PRKRA (DYT16).
Methods

Case ascertainment
Subjects were recruited from neurology clinics in Brisbane, Australia between 2003 and 2011. Diagnosis of sporadic primary dystonia was made by an experienced movement disorder specialist using standard diagnostic criteria. Cases were defined as "sporadic" if they were negative for the TOR1A ΔE302/303 mutation and either had an onset age greater than 30 years, or reported no family history of dystonia or dystonia-plus syndromes at time of recruitment.
Patients with focal, segmental, multifocal or generalised dystonia were included in this study.
A questionnaire was employed to ascertain clinical and epidemiological information from dystonia patients. Control subjects underwent similar data collection procedures and were excluded if screening suggested any possibility of movement or cognitive disorders. Informed consent was obtained from all participating subjects and human research ethical clearance was obtained from all participating institutions.
In total, there were 230 dystonia cases (mean age = 63 ± 14 years, 82 males/148 females, mean onset age = 46 ± 15 years) and 228 age-and gender-matched controls (mean age = 68 ± 11 years, 84 males/144 females). For 206 dystonia cases we had comprehensive phenotype information. 140 patients had focal dystonia, 51 had segmented dystonia, 10 had multifocal dystonia and 5 had generalised dystonia. Supplementary Table 1 summarises the characteristics for the five most prevalent dystonia subtypes in the dystonia sample. These subtypes are inclusive of patients with multiple presentations and as such some patients were included in more than one subgroup. Blood was collected from all subjects and DNA extracted by standard methods. A comprehensive mutation screen of all genes known to be involved in familial forms Newman et al. 6 of dystonia was not performed, however all dystonia cases were negative for the TOR1A ΔE302/303 mutation.
SNP genotyping and analyses
Genetic variables were selected to tag the vast majority of common genetic variation in the coding region of the TOR1A, TAF1, GCH1, THAP1, MR-1 (PNKD), SGCE, ATP1A3 and PRKRA genes ± 5 kb (minor allele frequencies > 10%, r 2 > 0.90). Haplotype-tagging SNPs were derived from the HapMap project CEU population (Data Rel 28/phase II+III, August10, on NCBI B36 assembly (http://hapmap.ncbi.nlm.nih.gov/) using the Haploview software package running Tagger (www.broad.mit.edu/mpg/haploview/). All TOR1A SNPs previously genotyped in published case-control association studies of sporadic primary dystonia were also genotyped here [7, 8, [14] [15] [16] [17] [18] [19] and, where possible, were used to complement or substitute tagging SNPs derived from HapMap data. Where complete coverage of a genetic region was not possible using HapMap data, SNPs were selected from the 1000 Genomes Project (http://www.1000genomes.org). In the case of THAP1, the polymorphisms c.-237_-236GA>TT, c.71+9C>A and c.71+126T>C were also genotyped.
Design and implementation of genotyping assays for selected SNPs was carried out by the Australian Genome Research Facility in Brisbane, using the MassARRAY genotyping platform (Sequenom, San Diego, USA). Genotyping reliability was verified by independently re-genotyping a random selection of 10% of the original sample and there were no conflicts.
Over the 56 genotyping assays, 96.9% of genotypes were successfully called. All statistical analyses were carried out in PLINK version 1.07 (http://pngu.mgh.harvard.edu/~purcell/plink/).
The odds ratios (ORs) for genotype associations (additive model) were calculated using logistic regression with adjustment for age and gender. Stratified analyses were also performed between case groups for each of the four most prevalent dystonia subtypes in our sample and nondiseased controls.
Meta-analysis
Candidate gene studies for the primary dystonias were identified using web-based MEDLINE database searches (PubMed). The keywords "dystonia" and "polymorphism*"
yielded 127 references in English, published between January 1966 and January 2011.
Additional references were obtained by reviewing citations within these 127 articles. Inclusion criteria were: (1) they were case-control studies in which the cases were clinically diagnosed with having a primary focal or segmental dystonia and controls were neurologically healthy; (2) the genotype and/or allele frequencies were reported; and (3) included polymorphisms in the TOR1A gene. No attempts were made to locate any unpublished studies, or those that were not available from online subscriptions or from institutional holdings. Genotype information from the current genotyping study was included in the meta-analyses.
Analysis was limited to SNPs that had been studied in three or more populations. Pooled data were analysed using the MIX program, version 1.7 (http://mix-for-meta-analysis.info/).
ORs were calculated for each individual study prior to a combined analysis based on reported genotypic and allelic information. Pooled data were first analysed using a fixed-effects model calculated by the Mantel-Haenszel method, and visualised using forest plots (P < 0.05). Because this approach assumes homogeneity between studies, the potential presence of heterogeneity was calculated using a Cochran's Q statistic. Analyses with a high degree of heterogeneity (Q statistic P < 0.1) were repeated using a random-effects model calculated as per the DerSimonian-Laird to adjust for between-study variability.
Results
Newman et al. To further characterise the common variation in the THAP1 genomic region, we complemented these variants with six SNPs identified in CEU individuals (minor allele frequency > 4%) as a part of the 1000 Genomes Project. In addition, one of the three HapMap-derived tagging SNPs for the TAF1 gene (rs5980758) failed quality control assessment during assay design. In an effort to compensate for this loss of coverage we sought to include two additional TAF1 SNPs (rs113203261 and rs5981112) selected from the 1000 Genomes Project, however only rs113203261 passed assay design and was genotyped. In total, 56 tagging SNPs covering the common genetic variation in and around the TOR1A, TAF1, GCH1, THAP1, MR-1 (PNKD),
SGCE, ATP1A3
and PRKRA genes (± 5 kb) were selected. All SNPs conformed to HardyWeinberg equilibrium in control subjects (P > 0.05), with the exception of GCH1 SNPs rs2183081 (P = 0.008) and rs7147286 (P = 0.04). These were excluded from further analysis.
TOR1A
No significant associations were seen between TOR1A SNPs and sporadic primary dystonia in our dataset (P > 0.05) ( Table 2 ). Given that associations have been reported in other populations [7, [14] [15] [16] [17] we decided to perform meta-analyses to improve power and see if our results were comparable with data from the seven published case-control association studies that have analysed TOR1A SNPs. Four of these SNPs have been examined in multiple studies and were suitable for meta-analyses -rs1182, rs3842225, rs1801968 and rs2297693 [7, 8, [14] [15] [16] [17] [18] [19] . In the case of one study [16] allele counts were calculated from reported minor allele frequencies and group size. Significant between-study heterogeneity was observed within the meta-analyses
for all SNPs except for rs1801968; these analyses were re-performed using a random-effects model to adjust for this variability. Overall, pooled allelic frequencies for each of the metaanalyses were not significantly different between cases and controls (P > 0.05) (Figure 2 ).
TAF1, GCH1, THAP1, PNKD, SGCE, ATP1A3 and PRKRA
In general, there were few differences in SNP frequencies between dystonia and control groups. Three GCH1 SNPs showed modest associations with primary dystonia. The frequencies of rs10483639 and rs3759664 were significantly higher in the controls (odd ratio (OR) = 0.697 (0.511 -0.949), P = 0.022; and OR = 0.629 (0.443 -0.894), P = 0.010, respectively). For rs12147422, the alternative allele was more common in the cases (OR = 1.702 (1.141 -2.537), P = 0.01) ( Table 2 ). No differences in genotype frequencies for the SNPs tagging the TAF1,
THAP1, MR-1 (PNKD), SGCE, ATP1A3
and PRKRA genes were seen between cases and controls (P < 0.05) ( Table 2) . Associations between GCH1 polymorphisms and cervical dystonia were observed when the case group was stratified based on the site of presentation (P < 0.05) ( Table 3) . Further stratification of case groups provided little useful data due to the limited numbers of cases in each group. However, the raw data is included in Supplementary Table 2 for completeness. None of the reported associations would survive any moderate multipletesting adjustment.
Discussion
Mutations in the TOR1A, TAF1, GCH1, THAP1, MR-1 (PNKD), SGCE, ATP1A3 and PRKRA genes have all been previously linked with familial dystonia syndromes. As associations between common variants in TOR1A and THAP1 and sporadic dystonia have been previously reported, it seemed reasonable to extend a candidate gene approach to all eight genes. There are other DYT genes such as SLC2A1 (DYT18) which could have been investigated as interesting Newman et al. 10 candidates in this project for association with primary dystonia. However, we limited our study to those genes where mutations lead to dystonia as a prominent (if not the sole) presenting symptom. SLC2A1 mutations have been associated with the GLUT1 deficiency syndromes, which have a highly variable phenotype of which paroxysmal dystonia may only be one of a constellation of possible signs [23] .
We employed a haplotype-tagging strategy to effectively cover the majority of common variability in the chosen genes to investigate associations with sporadic primary dystonia. A similar approach has been used to study TOR1A variants in a previous case-control association study [15] . Our analysis revealed few differences in SNP distribution between dystonia and control subjects. We did identify three SNPs in GCH1 associated with sporadic primary dystonia, although these associations would not survive an adjustment for multiple testing.
Using a minor allele frequency of 10%, our sample size had a statistical power of 90% to detect
ORs of greater than 1.900 when not corrected for multiple testing. When correcting for 56 tests, only ORs greater than 2.410 would be deemed significant [24] . We estimate our cohort size would need to be at least three times larger (n = 770) in order to satisfy multiple testing corrections and remain statistically powerful (>90%) [24] .
GCH1 encodes the enzyme GTP cyclohydrolase I, which is involved in the synthesis of tetrahydrobiopterin (BH4). BH4 is a necessary cofactor in the synthesis of L-DOPA and, by extension, other neurotransmitters including dopamine. Deficiencies in this production are the key neurophysiological hallmark of DYT5 DOPA-responsive dystonia [25] . In addition, altered dopamine neurotransmission is thought to be a feature of sporadic primary dystonia (see [26] for a review). Genetic variation in GCH1 has been associated with different levels of pain sensitivity and tolerance [27] . A "pain-protective" haplotype has been associated with reduced GCH1 expression and BH4 levels [28] . Our study included one of the SNPs of this haplotype (rs10483639) and the remaining SNPs are tagged by rs3759664 according to HapMap CEU Newman et al. 11 data. Taken together, these findings lend credence to the hypothesis that primary dystonia may arise through changes in dopamine neurotransmission. Given that the depletion of striatal dopamine is also feature of Parkinson's disease (PD), it is tempting to suggest that primary dystonia may share a common molecular pathway with PD. Interestingly, a similar association between the three significant GCH1 SNPs (rs10483639, rs12147422 and rs3759664) and a PD case group recruited in Brisbane was observed in our cohort (Supplementary Methods, Supplementary Table 3 ). Meta-analyses of several genome-wide association studies show associations between other GCH1 variants tagged by these SNPs and PD [29] .
Our analysis did not reveal strong associations in other DYT genes and susceptibility to sporadic primary dystonia. Furthermore, meta-analyses of four TOR1A SNPs demonstrated that they were not susceptibility factors for sporadic primary dystonia. This suggests that these genes are unlikely to be major determinants of susceptibility to this disorder. As the sporadic primary dystonias are a phenotypically heterogenous group of movement disorders, subtype-specific genetic risk factors may exist. We found preliminary evidence to suggest that SNPs in GCH1
are associated with a specific dystonia subtype (Table 3) . It is prudent to assume that these associations are simply spurious findings due to the small sample size. However, if replicated these results suggest that common variants of different DYT genes could confer susceptibility to individual dystonia subtypes. As such, these subtype-specific effects might be diluted by the phenotypic heterogeneity of a combined primary dystonia case group. While phenotype-specific genetic associations have not been widely explored in sporadic dystonia, associations between three TOR1A SNPs and specific dystonia subtypes have been recently reported. Rs1182 was associated with blepharospasm [8] and rs1801968 was a risk factor for blepharospasm, cervical dystonia and writer's cramp [7] , although a study published during the submission of this manuscript did not support these associations [30] . Additionally, rs3842225 was less frequent in patients with cervical dystonia and laryngeal dystonia compared with CEPH controls [16] . The
Newman et al. 12
genotype frequencies of several TOR1A SNPs highly correlated to rs3842225 were slightly different between controls and patients with oromandibular or laryngeal dystonia in our study (Supplementary Table 2 ). However sample sizes for these stratified analyses are generally small. Nevertheless, such phenotype-specific studies appear warranted if sample size issues could be sufficiently resolved, possibly through collaborative efforts. These studies may also clarify some of the inconsistencies between SNP association studies, like that of TOR1A, which may be in part due to the differences in the clinical composition of each study.
To our knowledge, this is the first study to analyse common variants in multiple DYT genes and the susceptibility to sporadic primary dystonia, and the first to demonstrate associations between GCH1 SNPs and sporadic primary dystonia. It is also the first study to perform meta-analyses on TOR1A SNPs in the context of sporadic primary dystonia. The advantages of our study are that we have covered the majority of common genetic variation around multiple DYT genes, have used a large study group and have examined the dystonia subtypes. The main limitation of our study is sufficient statistical power, especially for investigating subtype-specific genetic risk factors. In conclusion we suspect that common genetic variants around the DYT genes do not greatly confer susceptibility to sporadic primary dystonia. However, future work investigating GCH1 as a candidate gene as well as subtypespecific analyses is warranted. The rarity of dystonia as a phenotype means that such studies are likely to require collaborative studies. Overall result of the meta-analysis is shown as the diamond.
